Sökning: WFRF:(Jerlstrom T) >
Treatment and progn...
Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)
-
- Abdul-Sattar Aljabery, Firas (författare)
- Linköpings universitet,Linköping University,Avdelningen för kirurgi, ortopedi och onkologi,Medicinska fakulteten,Region Östergötland, Urologiska kliniken i Östergötland
-
- Liedberg, Fredrik (författare)
- Lund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Clinical Microbiology, Malmö,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Skåne University Hospital,Skane Univ Hosp, Sweden; Lund Univ, Sweden
-
- Häggström, Christel (författare)
- Uppsala University,Umeå University,Uppsala universitet,Endokrinkirurgi,Department of Biobank Research, Umeå University; Department of Public Health and Clinical Medicine, Nutritional Research, Umeå University,Uppsala Univ, Sweden; Umea Univ, Sweden
-
visa fler...
-
- Ströck, Viveka (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för urologi,Institute of Clinical Sciences, Department of Urology,Sahlgrenska Academy,Sahlgrenska University Hospital,Univ Gothenburg, Sweden; Sahlgrens Univ Hosp, Sweden
-
- Hosseini, A. (författare)
- Karolinska University Hospital,Karolinska Univ Hosp, Sweden
-
- Gardmark, T. (författare)
- Karolinska Institutet
-
- Sherif, A. (författare)
- Umeå University,Umea Univ, Sweden
-
- Jerlstrom, T. (författare)
- Örebro University,Orebro Univ, Sweden
-
- Malmström, Per-Uno (författare)
- Uppsala University,Uppsala universitet,Urologkirurgi,Uppsala Univ, Sweden
-
- Hagberg, Oskar (författare)
- Lund University,Lunds universitet,Klinisk mikrobiologi, Malmö,Forskargrupper vid Lunds universitet,Clinical Microbiology, Malmö,Lund University Research Groups,Lund Univ, Sweden
-
- Holmberg, Lars (författare)
- Uppsala University,Uppsala universitet,Endokrinkirurgi,King's College London,Uppsala Univ, Sweden; Kings Coll London, England
-
visa färre...
-
(creator_code:org_t)
- 2020-08-31
- 2020
- Engelska.
-
Ingår i: BJU International. - : Wiley. - 1464-4096 .- 1464-410X. ; 126:5, s. 625-632
- Relaterad länk:
-
http://uu.diva-porta...
-
visa fler...
-
https://doi.org/10.1...
-
https://uu.diva-port... (primary) (Raw object)
-
http://dx.doi.org/10...
-
https://liu.diva-por... (primary) (Raw object)
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://lup.lub.lu.s...
-
https://urn.kb.se/re...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Objective To study how patients with urinary bladder cancer (UBC) with previous or concomitant other primary cancers (OPCs) were treated, and to investigate their prognosis. Patients And Methods Using nationwide population-based data in the Bladder Cancer Data Base Sweden (BladderBaSe), we analysed the probability of treatment with curative intent, and UBC-specific and overall survival (OS) in patients with UBC diagnosed in the period 1997-2014 with or without OPC. The analyses considered the patient's characteristics, UBC tumour stage at diagnosis, and site of OPC. Results There were 38 689 patients, of which 9804 (25%) had OPCs. Those with synchronous OPCs more often had T2 and T3 tumours and clinically distant disease at diagnosis than those with UBC only. Patients with synchronous prostate cancer, female genital cancer and lower gastro-intestinal cancer were more often treated with curative intent than patients with UBC only. When models of survival were adjusted for age at diagnosis, marital status, education, year of diagnosis, Charlson Comorbidity Index and T-stage, UBC-specific survival was similar to patients with UBC only, but OS was lower for patients with synchronous OPC, explained mainly by deaths in OPC primaries with a bad prognosis. Conclusions OPC is common in patients with UBC. Treatment for UBC, after or in conjunction with an OPC, should not be neglected and carries just as high a probability of success as treatment in patients with UBC only. The needs of patients with UBC and OPC, and optimisation of their treatment considering their complicated disease trajectory are important areas of research.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Urologi och njurmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Urology and Nephrology (hsv//eng)
Nyckelord
- bladder cancer
- other primary cancer
- cohort study
- management
- outcome
- #uroonc
- #BladderCancer
- #blcsm
- #utuc
- 2nd malignant neoplasms
- cyclophosphamide therapy
- prostate cancers
- risk
- survivors
- Urology & Nephrology
- #BladderCancer
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Abdul-Sattar Alj ...
-
Liedberg, Fredri ...
-
Häggström, Chris ...
-
Ströck, Viveka
-
Hosseini, A.
-
Gardmark, T.
-
visa fler...
-
Sherif, A.
-
Jerlstrom, T.
-
Malmström, Per-U ...
-
Hagberg, Oskar
-
Holmberg, Lars
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Cancer och onkol ...
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Urologi och njur ...
- Artiklar i publikationen
-
BJU Internationa ...
- Av lärosätet
-
Göteborgs universitet
-
Uppsala universitet
-
Lunds universitet
-
Linköpings universitet
-
Karolinska Institutet